HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheryl H Baker Selected Research

Neoplasms (Cancer)

9/2012MGMT inhibition restores ERĪ± functional sensitivity to antiestrogen therapy.
6/2012Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.
7/2011Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.
5/2011A facile nanoparticle immunoassay for cancer biomarker discovery.
2/2011Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.
1/2011Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid.
10/2010Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics.
9/2010Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.
1/2010Angiogenesis: an update and potential drug approaches (review).
10/2009Blockade of MGMT expression by O6 benzyl guanine leads to inhibition of pancreatic cancer growth and induction of apoptosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheryl H Baker Research Topics

Disease

31Neoplasms (Cancer)
09/2012 - 04/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
05/2013 - 04/2002
8Neoplasm Metastasis (Metastasis)
06/2012 - 04/2002
5Lung Neoplasms (Lung Cancer)
03/2012 - 10/2007
4Adenocarcinoma
03/2009 - 08/2005
3Glioblastoma (Glioblastoma Multiforme)
09/2010 - 02/2006
2Ovarian Neoplasms (Ovarian Cancer)
07/2011 - 07/2002
2Glioma (Gliomas)
09/2010 - 02/2006
2Colonic Neoplasms (Colon Cancer)
03/2010 - 04/2007
2Renal Cell Carcinoma (Grawitz Tumor)
06/2006 - 11/2002
2Carcinoma (Carcinomatosis)
09/2002 - 07/2002
1Radiodermatitis
10/2012
1Xerostomia
10/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1Esophageal Neoplasms (Esophageal Cancer)
06/2012
1Carcinogenesis
06/2012
1Prostatic Neoplasms (Prostate Cancer)
05/2011
1Chronic Disease (Chronic Diseases)
01/2011
1Inflammation (Inflammations)
01/2011
1Pain (Aches)
01/2011
1Seizures (Absence Seizure)
09/2010
1Pneumonia (Pneumonitis)
06/2009
1Multiple Myeloma
05/2008
1Adenocarcinoma of Lung
10/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2007

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
06/2012 - 10/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011 - 04/2002
7tolfenamic acidIBA
06/2012 - 06/2006
7GemcitabineFDA Link
10/2009 - 04/2002
7ErbB Receptors (EGF Receptor)IBA
10/2007 - 04/2002
6Tyrosine Kinase InhibitorsIBA
01/2010 - 04/2002
6Epidermal Growth Factor (EGF)IBA
10/2007 - 04/2002
5Biological ProductsIBA
10/2009 - 07/2002
5Transforming Growth Factor alpha (TGF-alpha)IBA
10/2007 - 07/2002
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2007 - 04/2002
4ceric oxide (cerium dioxide)IBA
05/2013 - 06/2009
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2011 - 06/2006
4Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2008 - 04/2002
4PKI 166IBA
06/2006 - 04/2002
3Pharmaceutical PreparationsIBA
02/2011 - 04/2007
3src-Family KinasesIBA
12/2010 - 10/2005
3LuciferasesIBA
03/2010 - 02/2006
3Messenger RNA (mRNA)IBA
03/2009 - 06/2006
3Interleukin-8 (Interleukin 8)IBA
12/2005 - 11/2002
2Transcription Factors (Transcription Factor)IBA
06/2012 - 06/2006
2Firefly LuciferasesIBA
03/2012 - 02/2006
2SurvivinIBA
07/2011 - 03/2009
2Sp Transcription FactorsIBA
07/2011 - 02/2011
2LigandsIBA
01/2010 - 10/2007
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2008 - 05/2003
2AEE 788 (AEE788)IBA
10/2007 - 11/2005
2Phosphotransferases (Kinase)IBA
07/2006 - 10/2005
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2005 - 04/2002
2Interferon-alpha (Interferon Alfa)IBA
05/2003 - 07/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2002 - 07/2002
2Paclitaxel (Taxol)FDA LinkGeneric
09/2002 - 07/2002
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2013
1Cytochromes c (Cytochrome c)IBA
09/2012
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2012
1Fulvestrant (Faslodex)FDA Link
09/2012
1TamoxifenFDA LinkGeneric
09/2012
1Estrogen Receptor Modulators (Antiestrogen)IBA
09/2012
1nitrosobenzylmethylamineIBA
06/2012
1NitrosaminesIBA
06/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2011
1Biomarkers (Surrogate Marker)IBA
05/2011
1Blood Proteins (Serum Proteins)IBA
05/2011
1Protein CoronaIBA
05/2011
1Immunoglobulin G (IgG)IBA
05/2011
1Proto-Oncogene Proteins c-metIBA
02/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2010
1Tyrosine (L-Tyrosine)FDA Link
12/2010
1JNK Mitogen-Activated Protein KinasesIBA
12/2010
1SH2 Domain-Containing Protein Tyrosine PhosphatasesIBA
12/2010
1Contrast MediaIBA
10/2010
1O(6)-Methylguanine-DNA MethyltransferaseIBA
09/2010
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2010
1Alkylating AgentsIBA
09/2010
1Levetiracetam (Keppra)FDA LinkGeneric
09/2010
1Temozolomide (Temodar)FDA LinkGeneric
09/2010
1A-Form DNA (A-DNA)IBA
09/2010
1Monoclonal AntibodiesIBA
01/2010
1GuanineIBA
10/2009
1Drug CombinationsIBA
10/2009
1Immunoglobulins (Immunoglobulin)IBA
05/2008
1deoxyuridine triphosphateIBA
05/2008
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2008
1EndostatinsIBA
05/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2007

Therapy/Procedure

12Therapeutics
09/2012 - 04/2002
4Radiotherapy
05/2013 - 03/2009
3Oral Administration
07/2006 - 11/2002
2Injections
03/2010 - 05/2003
2Absorbable Gelatin Sponge
08/2005 - 07/2002
2Drug Therapy (Chemotherapy)
09/2002 - 04/2002
1Chemoprevention
06/2012
1Craniotomy
09/2010
1Aftercare (After-Treatment)
05/2008
1Intravenous Injections
05/2008